Literature DB >> 10668721

An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia.

S Costanzi-Porrini1, D Tessarolo, C Abbruzzese, M Liguori, T Ashizawa, M Giacanelli.   

Abstract

In spinocerebellar ataxia type 2 (SCA-2), a difference of three CAG repeats distinguishes normal alleles (14 to 31 repeats) from pathogenic alleles (34 to 57 repeats). All sequenced pathogenic alleles have a pure CAG repeat structure, whereas interrupted repeats have been seen exclusively in normal alleles. The authors present two patients with sporadic SCA with an interrupted 34-CAG repeat allele, (CAG)24(CAA)(CAG)9, who showed a phenotype compatible with SCA-2. The interrupted allele coding for a 34 pure polyglutamine tract may cause the SCA phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10668721     DOI: 10.1212/wnl.54.2.491

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Selective Forces Related to Spinocerebellar Ataxia Type 2.

Authors:  Lucas Schenatto Sena; Raphael Machado Castilhos; Eduardo Preusser Mattos; Gabriel Vasata Furtado; José Luiz Pedroso; Orlando Barsottini; Maria Marla Paiva de Amorim; Clecio Godeiro; Maria Luiza Saraiva Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

2.  Ataxin-2 repeat-length variation and neurodegeneration.

Authors:  Owen A Ross; Nicola J Rutherford; Matt Baker; Alexandra I Soto-Ortolaza; Minerva M Carrasquillo; Mariely DeJesus-Hernandez; Jennifer Adamson; Ma Li; Kathryn Volkening; Elizabeth Finger; William W Seeley; Kimmo J Hatanpaa; Catherine Lomen-Hoerth; Andrew Kertesz; Eileen H Bigio; Carol Lippa; Bryan K Woodruff; David S Knopman; Charles L White; Jay A Van Gerpen; James F Meschia; Ian R Mackenzie; Kevin Boylan; Bradley F Boeve; Bruce L Miller; Michael J Strong; Ryan J Uitti; Steven G Younkin; Neill R Graff-Radford; Ronald C Petersen; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2011-05-24       Impact factor: 6.150

3.  Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.

Authors:  Galen E B Wright; Jennifer A Collins; Chris Kay; Cassandra McDonald; Egor Dolzhenko; Qingwen Xia; Kristina Bečanović; Britt I Drögemöller; Alicia Semaka; Charlotte M Nguyen; Brett Trost; Fiona Richards; Emilia K Bijlsma; Ferdinando Squitieri; Colin J D Ross; Stephen W Scherer; Michael A Eberle; Ryan K C Yuen; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2019-05-16       Impact factor: 11.025

4.  ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Authors:  Lucia Corrado; Letizia Mazzini; Gaia Donata Oggioni; Bernadetta Luciano; Michela Godi; Alfredo Brusco; Sandra D'Alfonso
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

Review 5.  Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia.

Authors:  Priyanka Vishwakarma; Srinivasan Muthuswamy; Sarita Agarwal
Journal:  Intractable Rare Dis Res       Date:  2018-05

6.  PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.

Authors:  Zhenming Yu; Yongqing Zhu; Alice S Chen-Plotkin; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Robert G Kalb; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Aaron D Gitler; Nancy M Bonini
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

Review 7.  Parkinsonism in spinocerebellar ataxia.

Authors:  Hyeyoung Park; Han-Joon Kim; Beom S Jeon
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 8.  Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.

Authors:  Ming-Dong Wang; James Gomes; Neil R Cashman; Julian Little; Daniel Krewski
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

9.  Co-occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades.

Authors:  Chao Wu; Qiong Cai; Huajing You; Xiangxue Zhou; Dingbang Chen; Guiling Mo; Xunhua Li
Journal:  Mol Genet Genomic Med       Date:  2019-03-28       Impact factor: 2.183

10.  De novo mutations in ataxin-2 gene and ALS risk.

Authors:  José Miguel Laffita-Mesa; Jorge Michel Rodríguez Pupo; Raciel Moreno Sera; Yaimee Vázquez Mojena; Vivian Kourí; Leonides Laguna-Salvia; Michael Martínez-Godales; José A Valdevila Figueira; Peter O Bauer; Roberto Rodríguez-Labrada; Yanetza González Zaldívar; Martin Paucar; Per Svenningsson; Luís Velázquez Pérez
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.